Lonnie Moulder, Zenas BioPharma founder and executive chair
November 7, 2022 04:00 PM ESTUpdated November 8, 10:04 AM
Deals

Lon­nie Moul­der’s new biotech play grabs $118M, steer­ing in­to PhI­II and more deals

John Carroll

Editor & Founder

Se­r­i­al biotech en­tre­pre­neur Lon­nie Moul­der has scored some big wins along the way, most no­tably the $9 bil­lion he racked up sell­ing MGI and Tesaro …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

A rare neu­ro­log­i­cal dis­ease is Sage’s last, best hope af­ter fail­ures in de­pres­sion

No­var­tis strikes ra­dio­phar­ma deal with Ra­tio worth up to $745M

In­tel­lia touts first clin­i­cal out­comes on CRISPR-based AT­TR amy­loi­do­sis as­set

Scot­tish biotech de­buts with ‘Tro­jan horse’ plat­form for can­cer

Ei­sai ter­mi­nates Phase 3 tri­al of Dravet drug, cit­ing re­cruit­ment chal­lenges

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times